-
-
C287795-10mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C287795-25mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C287795-50mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C287795-5mgproduct description:CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1
-
C274306-10gCoomassie brilliant blue G-250
-
C274306-12×50gCoomassie brilliant blue G-250
-
C274306-25gCoomassie brilliant blue G-250
-
C274306-50gCoomassie brilliant blue G-250
-
C425057-1mlCoomassie brilliant blue G-250
-
D287037-1mgSubtilisin/Kex2p-like proprotein convertase inhibitor
-
D286584-100mgproduct description:A positive allosteric modulator for mGlu receptor subtype 5 (EC50 = 2 - 5.3 µM). No agonistic action on mGlu5. Renders 3-6 fold potentiation for Glu5 agonists. No effect on other mGlu receptor subtypes.Please note that the